Predictive model for non-malignant portal vein thrombosis associated with cirrhosis based on inflammatory biomarkers

Table 1 Baseline of demographics and clinical characteristics of the patients

Characteristics	non-PVT (n = 286)	PVT (n = 286)	P value
Age [mean (SD)]	52.60 (11.61)	52.87 (12.02)	0.783
Sex, n (%)
Male	161 (56.30)	163 (57.00)	0.933
Female	125 (43.70)	123 (43.00)
BMI [mean (SD)]	22.71 (3.28)	22.70 (3.02)	0.952
Etiology, n (%)
AIH	40 (14.00)	20 (7.00)	0.001
Hepatitis	200 (69.90)	189 (66.10)
Others	46 (16.10)	77 (26.90)
Ascites, n (%)
No	154 (53.80)	60 (21.00)	< 0.001
Yes	132 (46.20)	226 (79.00)
GOV, n (%)
No	73 (25.50)	7 (2.40)	< 0.001
Yes	213 (74.50)	279 (97.60)
ALBI grade, n (%)
1	95 (33.20)	53 (18.50)	< 0.001
2	163 (57.00)	192 (67.10)
3	28 (9.80)	41 (14.30)
CTP, n (%)
A	106 (37.10)	58 (20.30)	< 0.001
B	136 (47.60)	145 (50.70)
C	44 (15.40)	83 (29.00)

PVT: Portal vein thrombosis; AIH: Autoimmune hepatitis; GOV: Gastroesophageal varices; ALBI: Albumin-bilirubin grading; CTP: Child-Turcotte-Pugh score.